FVIII insufficiency as well as FVIII replacement therapy can be monitored. (Specialized hemostasis)

- Linearity: 1 - 144 (activity%).
- Detection limit: 0% (activity%)
- 5 minutes incubation and 3 minutes reading
- End point or kinetic

- 24 hour stability of reagents on analyzers
- Reagents refreezable 14 days at -20 ° C
- Insensitivity of TECHNOCHROM FVIII: C reagent to Emicizumab
 

- 2 vials of FXa-1 + αNAPAP substrate (2 mL)
- 2 vials x reagent A (Phospholipid, Albumin) (2 mL)
- 2 vials x reagent B (FIXaß, FX, Ca ++ , Albumin, Thrombin) (2 mL)
- 1 bottle x ref. Stand. FVIII 1 (≈ 130%) (1 mL)
- 1 bottle x ref. Stand. FVIII 2 (≈ 70%) (1 mL)
- 1 bottle x ref. Stand. FVIII 3 (≈ 10%) (1 mL)
- 1 bottle x ref. Stand. FVIII 4 (<0.5%) (1 mL)
- 3 vials x FVIII dilution buffer (30 mL)
- 2 vials x FVIII reaction buffer (8 mL)

Coagulation Control A
Coagulation Control N
Coagulation Reference